Mesothelioma patients whose T-cell counts bounce back quickly after a round of chemotherapy have a better chance of survival. They are also most likely to benefit from the addition of immunotherapy.
That’s the conclusion of a British study looking for prognostic indicators in mesothelioma patients undergoing a combination of chemotherapy.
hemotherapy is the most common first-line treatment for mesothelioma…